325®
EST. 1995 NY · NJ
FIG. 01 / EVOFEM BIOSCIENCES

A women's health brand, elevated.

Evofem held the science. They needed a brand that could hold the conversation. Twelve weeks to elevate the corporate identity, ship a new website, and complete the IR platform transition.

Client
Evofem Biosciences
Sector
Women's Health
Category
Biotech
Engaged
2021
Status
NASDAQ: EVFM
FIG. 01.A / Image to be supplied
FIG. 01.A / Evofem Biosciences brand application. Photography in production.

Evofem Biosciences develops innovations in women's reproductive and sexual health, including hormone-free contraception and protection from certain STIs. The science was differentiated. The brand was not.

They came to us with a 12-week window: expand the corporate brand, elevate the website, deliver an investor presentation, and oversee the IR platform transition.

We positioned the corporate brand as a powerhouse in women's healthcare, distinct from but aligned with the consumer-facing Phexxi brand.

A hierarchy of messaging built across imagery, typography, photography, color, and tone. Each layer addressed a different audience with the same conviction: investors, healthcare providers, and the women the work is ultimately for.

New brand strategy and guidelines documenting the elevated corporate position. Website rebuilt around education, agency, and trust. An investor presentation that read as the same brand at a higher resolution.

IR platform integration designed to feel like an editorial extension of the corporate site, not a regulatory afterthought. PR and email templates delivered as living systems, not one-offs.

"

We rebuilt the visual system around education, agency, and trust.

325 / Evofem case file
FIG. 01.B / Brand expansion to IR transition
12wk

A complete brand expansion, website rebuild, investor presentation, and IR platform transition delivered in twelve weeks. The corporate brand reads as a powerhouse in women's health.

325 / Evofem / Engagement complete 2021
Capabilities applied
§ 09   Engagement

Begin a conversation.

Sixty minutes. No deck. We ask about your science, your audiences, and what your last agency got wrong.

Begin a conversation